financetom
Business
financetom
/
Business
/
Bio-Techne, US Pharmacopeia Partner to Distribute Reference Standards
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bio-Techne, US Pharmacopeia Partner to Distribute Reference Standards
Jun 24, 2025 5:17 AM

07:59 AM EDT, 06/24/2025 (MT Newswires) -- Bio-Techne ( TECH ) said Tuesday that it has entered a distribution agreement with US Pharmacopeia, which will allow the life sciences company to sell US Pharmacopeia's monoclonal antibody and recombinant adeno-associated virus reference standards alongside its analytical platforms.

Financial terms of the deal were not disclosed.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lazydays Narrows Net Loss, Plans Store Divestitures To Refocus Amid Tough Q4
Lazydays Narrows Net Loss, Plans Store Divestitures To Refocus Amid Tough Q4
Mar 31, 2025
Lazydays Holdings, Inc. ( GORV ) shares are trading lower after the company released its fourth-quarter FY24 earnings results on Monday. The company reported a fourth-quarter sales decline of 19.2% year-on-year to $159.88 million from $198.03 million last year. Loss per share of $2.39 narrowed from a $7.59 loss last year. The gross profit margin (excluding LIFO) for the quarter...
Vaxcyte VAX-24 Vaccine Data Missed Wall Street Expectations, But Fundamentally Still Positive, Mizuho Securities Says
Vaxcyte VAX-24 Vaccine Data Missed Wall Street Expectations, But Fundamentally Still Positive, Mizuho Securities Says
Mar 31, 2025
09:51 AM EDT, 03/31/2025 (MT Newswires) -- Vaxcyte's ( PCVX ) results for vaccine candidate VAX-24 came in below some Wall Street expectations but were still fundamentally positive, Mizuho Securities said in a research note Monday. The clinical-stage company released this morning post-dose 3 and interim post-dose 4 data from a mid-stage trial of VAX-24, which was designed to prevent...
Dolby Labs, AMC Entertainment Expand US Partnership, Adding 40 Dolby Cinemas at AMC Locations
Dolby Labs, AMC Entertainment Expand US Partnership, Adding 40 Dolby Cinemas at AMC Locations
Mar 31, 2025
09:51 AM EDT, 03/31/2025 (MT Newswires) -- Dolby Laboratories ( DLB ) is expanding its partnership with AMC Entertainment ( AMC ) and will add another 40 Dolby Cinema sound and visual systems at AMC movie theater locations by the end of 2027, the companies said Monday. Following the upcoming expansion, more than 200 Dolby Cinema systems will be installed...
What's Going On With Chewy (CHWY) Stock?
What's Going On With Chewy (CHWY) Stock?
Mar 31, 2025
Chewy Inc ( CHWY ) shares are trading lower by 9.2% to $31.30 over the trailing five sessions. The stock has been volatile after the company last week reported fourth-quarter earnings, surpassing analyst expectations. What To Know: Chewy posted an adjusted EPS of 28 cents, a 55.6% increase from the prior year, exceeding the consensus estimate of 5 cents.  Revenue...
Copyright 2023-2026 - www.financetom.com All Rights Reserved